We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
+14.49%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$30.6M
(+13%)
Cap. Flow
+$3.25M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
95.88%
Holding
16
New
1
Increased
3
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$33.2M |
| 2 |
Labcorp
LH
|
+$26.3M |
| 3 |
Zimmer Biomet
ZBH
|
+$14.1M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$7.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$27M |
| 2 |
CVS Health
CVS
|
+$11.2M |
| 3 |
Cencora
COR
|
+$8.68M |
| 4 |
HCA Healthcare
HCA
|
+$8.16M |
| 5 |
Universal Health Services
UHS
|
+$7.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Tavio Capital held 16 positions worth $271M, up 13% from $241M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Tavio Capital's Q1 2019 filing shows 1 new, 3 increased, 5 reduced and 3 closed positions. Its largest new stake was Centene: 547,575 shares worth $29.1M. The largest sale was Wellcare Health Plans, Inc., an estimated $27M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 89% a quarter earlier.
- Tavio Capital's largest Q1 2019 buy was Centene: 547,575 shares worth $29.1M.
- Tavio Capital added most to Labcorp in Q1 2019, an estimated $26.3M increase.
- Tavio Capital's biggest Q1 2019 reduction was HCA Healthcare, cutting an estimated $8.16M.
- Tavio Capital fully exited Wellcare Health Plans, Inc. in Q1 2019, selling an estimated $27M.
- Tavio Capital's ten largest holdings make up 96% of its $271M portfolio in Q1 2019.
- Tavio Capital opened 1 new position and closed 3 in Q1 2019.
- Tavio Capital's portfolio value rose 13% quarter-over-quarter to $271M.
Based on Tavio Capital's 13F filing for Q1 2019, filed 14 May 2019.